TipRanks
Nunzia Pharmaceutical (NUNZ)
OTHER OTC:NUNZ
US Market
NUNZ
Nunzia Pharmaceutical
RESEARCH TOOLSreports

Nunzia Pharmaceutical (NUNZ) Ratios

3 Followers

Nunzia Pharmaceutical Ratios

NUNZ's free cash flow for Q3 2022 was $0.00. For the 2022 fiscal year, NUNZ's free cash flow was decreased by $ and operating cash flow was $0.00. See a summary of the company’s cash flow.
Ratios
TTM
Dec 21Dec 20Dec 19Dec 18
Liquidity Ratios
Current Ratio
 <0.01 <0.01 0.00 0.00 0.00
Quick Ratio
 <0.01 <0.01 0.00 0.00 0.00
Cash Ratio
 <0.01 <0.01 0.00 0.00 0.00
Solvency Ratio
 -0.04 -783.73 -2.77K 6.12 -0.03
Operating Cash Flow Ratio
 -0.87 -0.87 -247.23 -0.17 0.00
Short-Term Operating Cash Flow Coverage
 -0.89 -0.89 -854.21 0.00 0.00
Net Current Asset Value
$ -99.17K$ -99.17K$ -36.40K$ -22.57K$ -293.97K
Leverage Ratios
Debt-to-Assets Ratio
 18.99 18.99 0.00 0.00 0.00
Debt-to-Equity Ratio
 -1.03 -1.03 -0.39 0.00 -0.08
Debt-to-Capital Ratio
 29.81 29.81 -0.63 0.00 -0.08
Long-Term Debt-to-Capital Ratio
 0.00 0.00 -0.63 0.00 0.00
Financial Leverage Ratio
 -0.05 -0.05 0.00 0.00 0.00
Debt Service Coverage Ratio
 0.00 -783.69 -0.10 0.00 -1.18
Interest Coverage Ratio
 -41.92K -41.92K >-0.01 0.00 0.00
Debt to Market Cap
 2.24 <0.01 <0.01 0.00 <0.01
Interest Debt Per Share
 <0.01 <0.01 0.32 0.00 <0.01
Net Debt to EBITDA
 0.00 >-0.01 >-0.01 0.00 -0.85
Profitability Margins
Gross Profit Margin
0.00%0.00%0.00%0.00%0.00%
EBIT Margin
0.00%0.00%0.00%0.00%0.00%
EBITDA Margin
0.00%0.00%0.00%0.00%0.00%
Operating Profit Margin
0.00%0.00%0.00%0.00%0.00%
Pretax Profit Margin
0.00%0.00%0.00%0.00%0.00%
Net Profit Margin
0.00%0.00%0.00%0.00%0.00%
Continuous Operations Profit Margin
0.00%0.00%0.00%0.00%0.00%
Net Income Per EBT
100.00%100.00%100.00%100.00%100.00%
EBT Per EBIT
100.00%100.00%256862.53%100.00%68.36%
Return on Assets (ROA)
-1521431.14%-1521431.14%0.00%0.00%0.00%
Return on Equity (ROE)
101661.22%82894.04%170049.71%148.99%6.32%
Return on Capital Employed (ROCE)
82890.08%82890.08%108.03%148.99%9.24%
Return on Invested Capital (ROIC)
-2387913.98%-2387913.98%152.03%148.99%10.03%
Return on Tangible Assets
-1521431.14%-1521431.14%0.00%0.00%0.00%
Earnings Yield
-255635.26%-39.32%-11.82%>-0.01%>-0.01%
Efficiency Ratios
Receivables Turnover
 0.00 0.00 0.00 0.00 0.00
Payables Turnover
 0.00 0.00 0.00 0.00 0.00
Inventory Turnover
 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
 0.00 0.00 0.00 0.00 0.00
Asset Turnover
 0.00 0.00 0.00 0.00 0.00
Working Capital Turnover Ratio
 0.00 0.00 0.00 0.00 0.00
Cash Conversion Cycle
 0.00 0.00 0.00 0.00 0.00
Days of Sales Outstanding
 0.00 0.00 0.00 0.00 0.00
Days of Inventory Outstanding
 0.00 0.00 0.00 0.00 0.00
Days of Payables Outstanding
 0.00 0.00 0.00 0.00 0.00
Operating Cycle
 0.00 0.00 0.00 0.00 0.00
Cash Flow Ratios
Operating Cash Flow Per Share
 >-0.01 >-0.01 -0.03 >-0.01 0.00
Free Cash Flow Per Share
 >-0.01 >-0.01 -0.03 >-0.01 0.00
CapEx Per Share
 0.00 0.00 0.00 0.00 0.00
Free Cash Flow to Operating Cash Flow
 1.00 1.00 1.00 1.00 0.00
Dividend Paid and CapEx Coverage Ratio
 0.00 0.00 0.00 0.00 0.00
Capital Expenditure Coverage Ratio
 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Coverage Ratio
 -0.89 -0.89 -391.30 0.00 0.00
Operating Cash Flow to Sales Ratio
 0.00 0.00 0.00 0.00 0.00
Free Cash Flow Yield
-199.71%-0.04%-1.05%>-0.01%0.00%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 >-0.01 -2.54 -8.46 -81.46K -135.45K
Price-to-Sales (P/S) Ratio
 0.00 0.00 0.00 0.00 0.00
Price-to-Book (P/B) Ratio
 -0.32 -2.11K -14.39K -121.37K -8.56K
Price-to-Free Cash Flow (P/FCF) Ratio
 -0.50 -2.29K -94.96 -721.04K 0.00
Price-to-Operating Cash Flow Ratio
 -0.35 -2.29K -94.96 -721.04K 0.00
Price-to-Earnings Growth (PEG) Ratio
 <0.01 0.10 >-0.01 0.00 0.00
Enterprise Value Multiple
 0.00 -2.55 -94.55 19.82K -92.60K
Enterprise Value
 140.76K 198.62M 854.70M 2.74B 2.52B
EV to EBITDA
 0.00 -2.55 -94.55 19.82K -92.60K
EV to Sales
 0.00 0.00 0.00 0.00 0.00
EV to Free Cash Flow
 -1.62 -2.29K -94.97 -721.04K 0.00
EV to Operating Cash Flow
 -1.62 -2.29K -94.97 -721.04K 0.00
Tangible Book Value Per Share
 >-0.01 >-0.01 >-0.01 >-0.01 >-0.01
Shareholders’ Equity Per Share
 >-0.01 >-0.01 >-0.01 >-0.01 >-0.01
Tax and Other Ratios
Effective Tax Rate
 0.00 0.00 0.00 0.00 0.00
Revenue Per Share
 0.00 0.00 0.00 0.00 0.00
Net Income Per Share
 -0.26 -0.26 -0.35 >-0.01 >-0.01
Tax Burden
 1.00 1.00 1.00 1.00 1.00
Interest Burden
 1.00 1.00 11.18 1.00 0.85
Research & Development to Revenue
 0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
 0.00 0.00 0.00 0.00 0.00
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 0.00 0.00
Income Quality
 <0.01 <0.01 1.00 0.11 0.00
Currency in USD